We have developed a simple and effective method, designated linker cap
ture subtraction (LCS), for cloning differentially expressed genes bet
ween two cell types or between cells treated in two different ways. In
the first step of the method, two mRNA populations are converted to d
ouble-stranded cDNAs, fragmented, and ligated to linkers for PCR ampli
fication. In the second step, the linkered DNA (tester) from one mRNA
population is hybridized to an excess of the unlinkered DNA (driver) f
rom the other mRNA population, followed by incubation with mung bean n
uclease which digests single-stranded DNA specifically. This leaves on
ly tester-tester homohybrids to be amplified by PCR in the following s
tep, so as to achieve an enrichment of tester-specific sequences. The
amplified PCR products are then used as tester for another round of su
btraction. The process of subtraction is carried out three times, and
the final PCR products are inserted into a vector for clonal analysis.
We have used the strategy to begin to clone and identify the genes ex
pressed differentially between the human prostate cancer cell lines LN
CaP and PC-3, which have different tumorigenic and metastatic potentia
ls. We demonstrated strong enrichment of target sequences. We also rep
ort the identities of two of the genes expressed differentially in the
se cell lines. One is prostate-specific antigen (PSA) which is known t
o be expressed in LNCaP but not in PC-3. The other is vimentin, the di
fferential expression of which has not been reported previously in the
se prostate cancer cells. (C) 1996 Academic Press, Inc.